E139 – SGLT2 inhibitors for kidney and heart disease
Normally used as a glucose-lowering agent in the treatment of type 2 diabetes, SGLT2 inhibitors have been found to have beneficial effects in patients with heart failure and kidney disease. Jo Cheah finds out more from cardiologist John Atherton.
Create your
podcast in
minutes
It is Free